| Name |
|---|
SMAR GeneSpinal muscular atrophy, chronic distal, autosomal recessive |
SMAL Genespinal muscular atrophy, congenital nonprogressive, of lower limbs |
SMAJ GeneSpinal muscular atrophy, Jokela type |
MDRV Genemuscular dystrophy, with rimmed vacuoles |
MLIP Genemuscular LMNA-interacting protein Predicted to enable lamin binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of cardiac muscle hypertrophy in response to stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Predicted to be located in PML body; nuclear envelope; and sarcolemma. [provided by Alliance of Genome Resources, Mar 2025] |
LGMD1H Genelimb girdle muscular dystrophy 1H (autosomal dominant) |
LGMD1G Genelimb girdle muscular dystrophy 1G (autosomal dominant) |
MDC1B GeneMuscular dystrophy, congenital, 1B |
FSHMD1A Genefacioscapulohumeral muscular dystrophy 1A Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary disease of muscle. Patients with FSHD have a chromosomal rearrangement within the subtelomeric region of chromosome 4 (4q35). This region is composed mainly of a polymorphic repeat structure consisting of 3.3 kb repeat units, designated D4Z4. The number of repeat units varies from 10 to more than 100 in the population, however, in FSHD patients only 1-10 repeat units is observed because of a deletion of an integral number of these units. FSHD is caused by an epigenetic mechanism involving the contraction of a subtelomeric macrosatellite repeat, which results in marked hypomethylation of the contracted D4Z4 allele. It is likely not the structure, but the deregulation of transcription of one or more genes as a result of repeat-contraction-mediated chromatin alterations, that causes FSHD. [provided by RefSeq, Sep 2011] |
FSHMD1B Genefacioscapulohumeral muscular dystrophy 1B |
SCA18 Genespinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy) |
MDCMP Genemuscular dystrophy, congenital, merosin-positive |
LALL GeneLymphomatous acute lymphoblastic leukemia |
BFIS1 Genebenign familial infantile convulsions |
ALL2 GeneLeukemia, acute lymphoblastic, susceptibility to, 2 |
STARP1 Genesteroidogenic acute regulatory protein pseudogene 1 |
NYS5 GeneNystagmus 5, infantile periodic alternating |
CLN6 Geneceroid-lipofuscinosis, neuronal 6, late infantile, variant This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008] |
BFIS4 GeneConvulsions, benign familial infantile, 4 |
AIR GeneAcute insulin response (2) |
PKDTS Genepolycystic kidney disease, infantile severe, with tuberous sclerosis |
TAL1 GeneT-cell acute lymphocytic leukemia 1 Enables several functions, including E-box binding activity; RNA polymerase II-specific DNA-binding transcription factor binding activity; and histone deacetylase binding activity. Involved in several processes, including myeloid cell differentiation; positive regulation of cellular component organization; and positive regulation of erythrocyte differentiation. Located in chromatin and nucleoplasm. Part of transcription regulator complex. Implicated in acute lymphoblastic leukemia. [provided by Alliance of Genome Resources, Mar 2025] |
TAL2 GeneT-cell acute lymphocytic leukemia 2 This intronless gene encodes a helix-loop-helix protein. Translocations between this gene on chromosome 9 and the T-cell receptor beta-chain locus on chromosome 7 have been associated with activation of the T-cell acute lymphocytic leukemia 2 gene and T-cell acute lymphoblastic leukemia. [provided by RefSeq, Mar 2009] |
BFIC2 GeneBenign familial infantile convulsions-2 |
EIM GeneInfantile myoclonic epilepsy |
GLC3B Geneglaucoma 3, primary infantile, B |
IHPS2 GenePyloric stenosis, infantile hypertrophic, 2 |
STAR Genesteroidogenic acute regulatory protein The protein encoded by this gene plays a key role in the acute regulation of steroid hormone synthesis by enhancing the conversion of cholesterol into pregnenolone. This protein permits the cleavage of cholesterol into pregnenolone by mediating the transport of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane. Mutations in this gene are a cause of congenital lipoid adrenal hyperplasia (CLAH), also called lipoid CAH. A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jul 2008] |
ALL1 GeneLeukemia, acute lymphocytic, susceptibility to, 1 |
BLACE GeneB-cell acute lymphoblastic leukemia expressed |
CMS1A1 Genemyasthenia gravis, familial infantile, 1 |
BAALC Genebrain and acute leukemia, cytoplasmic This gene was identified by gene expression studies in patients with acute myeloid leukemia (AML). The gene is conserved among mammals and is not found in lower organisms. Tissues that express this gene develop from the neuroectoderm. Multiple alternatively spliced transcript variants that encode different proteins have been described for this gene; however, some of the transcript variants are found only in AML cell lines. [provided by RefSeq, Jul 2008] |
AMLCR2 Geneacute myeloid leukemia chromosome region 2 |
IHPS5 GenePyloric stenosis, infantile hypertrophic, 5 |
IHPS4 GenePyloric stenosis, infantile hypertrophic, 4 |
IHPS3 GenePyloric stenosis, infantile hypertrophic, 3 |
STAT3 Genesignal transducer and activator of transcription 3 (acute-phase response factor) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. This gene also plays a role in regulating host response to viral and bacterial infections. Mutations in this gene are associated with infantile-onset multisystem autoimmune disease and hyper-immunoglobulin E syndrome. [provided by RefSeq, Aug 2020] |
NALT1 GeneNOTCH1 associated lncRNA in T cell acute lymphoblastic leukemia 1 |